Generic Drug Makers Back Away From Health Reform Tab

Main Category: Pharma Industry / Biotech Industry
Also Included In: Health Insurance / Medical Insurance
Article Date: 16 Oct 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated

Kaiser Health News staff writer Phil Galewitz reports on the position generic drug makers have taken regarding how the costs of health reform should be paid. "Generic drug makers - which have saved Americans hundreds of billions of dollars in the past decade with their low-cost, copycat medicines - don't think they should join other health industries to finance a health care overhaul" (10/15).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Generic Drug Makers Back Away From Health Reform Tab." Medical News Today. MediLexicon, Intl., 16 Oct. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/167598.php>

APA
Kaiser. (2009, October 16). "Generic Drug Makers Back Away From Health Reform Tab." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/167598.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »